KCR’s new service – Trial Execution Consulting – has been designed to support biotechnology and pharma companies in translating their scientific objectives into operations. With the increasing complexity of studies, and time and cost pressure, the clinical trial execution necessitates extensive knowledge and experience to support the operations for efficient and effective outcome.
Anna Baran, chief medical officer at KCR and head of the Trial Execution Consulting service, in her interviews describes in detail the new service offer, who are the customers to be supported, and why KCR has added consulting to its services portfolio.
Watch the 1st video on What is Trial Execution Consulting about?
Watch the 2nd video on Who KCR offers Trial Execution Consulting to?
Watch the 3rd video on Why KCR introduces Trial Execution Consulting?
If you would like to learn more about KCR Trial Execution Consulting service, please contact Joanna Lewandowska, PR & Marketing at email@example.com. Please include your full contact details in the query.
KCR is a contract research organization providing clinical development solutions for the pharmaceutical, biotechnology and medical device industries. The company supports clients with full-service capabilities across three main services: Trial Execution (TE), Functional Service Provision (FS) and Trial Execution Consulting (TC) over a broad range of therapeutic areas. KCR operates across four main regions: North America, Western Europe, Central Europe, and Eastern Europe with hubs located in Boston, U.S., Berlin, Germany, Warsaw, Poland and Kiev, Ukraine. KCR’s geographical locations allow for optimized delivery of trial execution strategies to develop life-changing therapies.
KCR: We see human behind every number.
Associate Director, PR & Marketing
mobile: (+48) 605 053 164